首页> 外文OA文献 >Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

【2h】

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

机译：用克拉屈滨片治疗的复发性多发性硬化症患者，脑萎缩率降低与残疾进展风险降低相关。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
De Stefano, N; Giorgio, A; Battaglini, M; De Leucio, A; Hicking, C; Dangond, F; Giovannoni, G; Sormani, Mp;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets [J] . Nicola De Stefano, Antonio Giorgio, Marco Battaglini, Multiple sclerosis: clinical and laboratory research . 2018,第2期

机译：减少的脑萎缩率与患者患者的残疾进展风险降低有关，复发用克兰汀片剂处理的多发性硬化
2. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. [J] . Zivadinov R, Locatelli L, Cookfair D, Multiple sclerosis: clinical and laboratory research . 2007,第4期

机译：干扰素beta-1a主要通过减少灰质萎缩来减缓复发性多发性硬化症中脑萎缩的进展。
3. Year-by-year lymphopenia rates in patients with relapsing multiple sclerosis (RMS) treated with cladribine tablets 3.5mg/kg in CLARITY and re-treated in CLARITY Extension [J] . Cook Stuart, Comi Giancarlo, Giovannoni Gavin, Multiple sclerosis: clinical and laboratory research . 2017,第13期

机译：复发多发性硬化症（RMS）的患者年度淋巴病率为3.5mg / kg，并在清晰度的延伸中重新治疗
4. Complexity of cerebral atrophy evaluation in relapsing-remitting multiple sclerosis context [C] . Souplet J.C., Cohen M., Lebrun C., 2011 8th IEEE International Symposium on Biomedical Imaging: From Nano to Macro . 2011

机译：复发性多发性硬化症背景下脑萎缩评估的复杂性
5. An investigation of early relapsing-remitting multiple sclerosis patients using diffusion tensor imaging and spectroscopy. [D] . Zaini, Wan Hazlin. 2013

机译：使用扩散张量成像和光谱法对早期复发缓解型多发性硬化症患者进行调查。
6. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets [O] . Nicola De Stefano, Antonio Giorgio, Marco Battaglini, -1

机译：用克拉屈滨片治疗的复发性多发性硬化症患者脑萎缩率降低与残疾进展风险降低相关
7. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. [O] . De Stefano N, Giorgio A, Battaglini M, 2017

机译：降低脑萎缩率与克拉屈滨片治疗复发性多发性硬化患者的残疾进展风险降低有关。

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

著录项

引文网络

相似文献

相关主题

期刊订阅